Rise Expected in Radiation-Induced Mesothelioma
James Stevenson, M.D., renowned oncologist at the Cleveland Clinic, didn't need to see the recent study to know the face of malignant pleural mesothelioma was changing.
He sees it in his waiting room all the time.
While occupational exposure to asbestos, which is still the No. 1 cause of the rare disease, continues dropping significantly, the rate of mesothelioma remains steady. And the patients don't look the same anymore.
Other causes, it seems, are emerging, and they may be rising.
"The general thinking is that these non-asbestos related cases will increase as we move forward," said Stevenson, a mesothelioma special...
Source: Asbestos and Mesothelioma News - February 12, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news
Stem cell donation: make a friend, save a life
If a stranger save your life, wouldn't you want to meet them? Many stem cell recipients do – and forge lasting friendships with their donorsSomewhere in London is my perfect match. He is well-built, a year older than me, popular with my friends and family – a real hero. We've never met.He is my stem cell donor, a 10/10 fit for my blood tissue type, according to our human leukocyte antigen (HLA) – the unique "barcode" we each have on our immune system's cells – which allows the body to distinguish itself from foreign bodies so it can fight invading organisms. When I was diagnosed with high-risk leukaemia last Februa...
Source: Guardian Unlimited Science - February 2, 2014 Category: Science Authors: Hannah Partos Tags: The Guardian Health & wellbeing Society Features Stem cells Life and style Organ donation Source Type: news
Breast cancer in young women after treatment for Hodgkin's disease
(Deutsches Aerzteblatt International) Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ärzteblatt International. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2014 Category: Cancer & Oncology Source Type: news
The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1
The malignant Hodgkin/Reed-Sternberg (RS) cell is embedded in a collagen-rich microenvironment. In this week's issue of Blood, Cader and colleagues elucidate a potentially important collagen-mediated signaling pathway supporting the survival of RS cells in Epstein-Barr virus-positive (EBV+) Hodgkin Disease (HD), demonstrating that expression of the EBV latent membrane protein-1 (LMP1) upregulates the expression of discoidin domain receptor 1 (DDR1), a collagen-activated receptor tyrosine kinase. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 24, 2013 Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news
Discovery of CXCR4 mutations in Waldenstrom's Macroglobulinemia helps identify which patients are more likely to benefit from ibrutinib
In nearly one-third of patients with Waldenstrom's Macroglobulinemia, a specific genetic mutation switches on the disease, and a new drug that blocks the defective gene can arrest the disease in animal models, researchers at Dana-Farber Cancer Institute and allied institutions reported at the 2013 annual meeting of the American Society of Hematology (ASH). The finding may open the way to clinical trials of the drug in Waldenstrom's patients whose tumor cells carry the mutation.Waldenstrom's is a form of non-Hodgkin lymphoma diagnosed in 2,000 to 3,000 people in the United States each year. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2013 Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news
Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients
Study found increased survival rate but only for those with highest-risk diseaseSource: HealthDay
Related MedlinePlus Pages: Lymphoma, Stem Cells (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 31, 2013 Category: Consumer Health News Source Type: news
'No link' between nuclear plants and child cancer
This report suggested that there were more cases of cancer than expected in young people in the vicinity of what is now known as the Sellafield nuclear power plant. This led to the setting up of the Committee on Medical Aspects of Radiation in the Environment (COMARE), which analyses data on rates of cancer in children in the areas around nuclear plants in Great Britain.
A report from COMARE in 2005 found that although a number of excess cases of some kinds of childhood cancer were found for nuclear sites whose main function was not the generation of electricity they “found no evidence of excess numbers of cases in any l...
Source: NHS News Feed - September 13, 2013 Category: Consumer Health News Tags: Cancer Source Type: news
Microbiota Predict Chemotherapy-Induced DiarrheaMicrobiota Predict Chemotherapy-Induced Diarrhea
For the first time, researchers have linked changes in gut microbiota and chemotherapy-induced diarrhea in patients with non-Hodgkin's lymphoma. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Hodgkin Lymphoma Treatment Tied to Higher Risk of Stomach Cancer in Study
Chemo, radiation doses to the stomach found to raise odds
Source: HealthDay
Related MedlinePlus Pages: Cancer Chemotherapy, Hodgkin Disease, Stomach Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 28, 2013 Category: Consumer Health News Source Type: news
NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer
While the cure rate for this disease is high, there is a risk of developing secondary cancers. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 26, 2013 Category: American Health Source Type: news
'Cancer was a blessing in disguise': Overweight Hodgkins Lymphone survivor Rick Keyworth, from Stockport, beats disease to become personal trainer
Rick Keyworth, from Stockport, was diagnosed with Hodgkins Lymphoma aged 21. But it was the wake-up call he needed. (Source: the Mail online | Health)
Source: the Mail online | Health - August 14, 2013 Category: Consumer Health News Source Type: news
Regular Echo Exams to Detect Radiation-Induced Heart DiseaseRegular Echo Exams to Detect Radiation-Induced Heart Disease
A joint European-American consensus statement is the first to recommend an echo exam every five to 10 years in patients who have received radiotherapy to the chest for Hodgkin's disease or breast, lung, or esophageal cancer. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 22, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
Regular echo exams warranted to detect radiation-induced heart disease
A joint European-American consensus statement is the first to recommend an echo exam every five to 10 years in patients who have received radiotherapy to the chest for Hodgkin's disease or breast, lung, or esophageal cancer. (Source: theHeart.org)
Source: theHeart.org - July 22, 2013 Category: Cardiology Source Type: news
Radiotherapy Is NOT Essential to Cure Diffuse Large B-Cell Non-Hodgkin Lymphoma
DLBCL of any stage remains a systemic disease with early hematogenous spread. Thus, arguments advocating the role of IFRT do not truly address disease biology, and all future efforts to cure patients will require improved systemic therapy. (Source: Cancer Network)
Source: Cancer Network - May 15, 2013 Category: Cancer & Oncology Source Type: news
ACE Inhibitor Can Limit Radiation Damage To Lungs And Heart For Cancer Patients
Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found. [1] Common cancers such as breast, oesophagus, lung, and Hodgkin's lymphoma are frequently treated with radiotherapy, but the radiation dose that can be given safely is limited by the sensitivity of the health lung tissue which is also irradiated... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 22, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
